BRENDA CORBIN: Open Payments
NPI 1629279278 · PONTE VEDRA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 52 payments from 19 companies in 2025. Trend: 2023 $3,441 · 2024 $1,948 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $252 |
| Amgen Inc. | 9 | $245 |
| PFIZER INC. | 6 | $127 |
| Novo Nordisk Inc | 4 | $101 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Lilly USA, LLC | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Exact Sciences Corporation | 2 | $51 |
Products named: BREZTRI, REPATHA, ELIQUIS, OTEZLA, Wegovy, TRELEGY ELLIPTA, FARXIGA, REXULTI.
Industry payments across FL — which companies pay providers there.
